ProfileGDS5678 / 1452709_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 84% 83% 83% 87% 84% 83% 83% 84% 83% 82% 83% 85% 84% 83% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 16.1667984
GSM967853U87-EV human glioblastoma xenograft - Control 26.1340583
GSM967854U87-EV human glioblastoma xenograft - Control 36.1557783
GSM967855U87-EV human glioblastoma xenograft - Control 46.9227787
GSM967856U87-EV human glioblastoma xenograft - Control 56.2482884
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 15.8265183
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 25.9401583
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 36.1421884
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 46.0256683
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 16.0456882
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 26.0400283
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 36.4582485
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 46.1597484
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 56.0352283